Skip to content
Back to OPK

Opko Health, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
35
Purchases
33
Sales
2
Purchase value
$2.99M
Sale value
$24.58K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

John a PaganelliDirector
4
Filed Nov 5, 2026Period of report Nov 5, 20260001193125-26-449786
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 5, 2026
Common Stock4,426$1.78$7.88K389,914Direct
SaleNov 5, 2026
Common StockF19,175$1.82$16.70K0IndirectSee Footnote
Filing footnotes · 1
  1. F1These securities are owned by Mr. Paganelli's spouse. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.
Open on SEC EDGAR
John a PaganelliDirector
4
Filed Mar 20, 2026Period of report Mar 20, 20260001193125-26-117703
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMar 20, 2026
Common Stock10,000$1.135$11.35K394,340Direct
Filing footnotes · 1
  1. F1These securities are owned by Mr. Paganelli's spouse. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.
Open on SEC EDGAR
Frost Gamma Investments Trust10% owner
Phillip MD et AL FrostDirector · CEO & Chairman · 10% owner
4
Filed Nov 21, 2025Period of report Nov 21, 20250001193125-25-291590
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 21, 2025
Common StockF1102,371$1.30$133.08K216,228,819IndirectSee Footnote
PurchaseNov 21, 2025
Common StockF13,894$1.32$5.14K216,232,713IndirectSee Footnote
PurchaseNov 21, 2025
Common StockF189,375$1.325$118.42K216,322,088IndirectSee Footnote
PurchaseNov 21, 2025
Common StockF1191,490$1.33$254.68K216,513,578IndirectSee Footnote
PurchaseNov 21, 2025
Common StockF1192,870$1.335$257.48K216,706,448IndirectSee Footnote
Filing footnotes · 2
  1. F1The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  2. F2These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of seven limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Open on SEC EDGAR
Frost Gamma Investments Trust10% owner
Phillip MD et AL FrostDirector · CEO & Chairman · 10% owner
4
Filed Nov 20, 2025Period of report Nov 20, 20250001193125-25-290115
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 20, 2025
Common StockF1119,129$1.32$157.25K215,665,577IndirectSee Footnote
PurchaseNov 20, 2025
Common StockF147,105$1.325$62.41K215,712,682IndirectSee Footnote
PurchaseNov 20, 2025
Common StockF1211,948$1.33$281.89K215,924,630IndirectSee Footnote
PurchaseNov 20, 2025
Common StockF1161,818$1.335$216.03K216,086,448IndirectSee Footnote
PurchaseNov 20, 2025
Common StockF124,579$1.34$32.94K216,111,027IndirectSee Footnote
PurchaseNov 20, 2025
Common StockF11,757$1.345$2.36K216,112,784IndirectSee Footnote
PurchaseNov 20, 2025
Common StockF113,664$1.35$18.45K216,126,448IndirectSee Footnote
Filing footnotes · 2
  1. F1The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  2. F2These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of seven limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Open on SEC EDGAR
Frost Gamma Investments Trust10% owner
Phillip MD et AL FrostDirector · CEO & Chairman · 10% owner
4
Filed Nov 19, 2025Period of report Nov 19, 20250001193125-25-288284
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 19, 2025
Common StockF136,325$1.28$46.50K215,002,773IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF158,160$1.285$74.74K215,060,933IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF1300$1.29$387.00215,061,233IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF121,236$1.295$27.50K215,082,469IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF130,082$1.30$39.11K215,112,551IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF112,993$1.305$16.96K215,125,544IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF166,504$1.31$87.12K215,192,048IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF1198,904$1.315$261.56K215,390,952IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF1155,496$1.32$205.25K215,546,448IndirectSee Footnote
Filing footnotes · 2
  1. F1The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  2. F2These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of seven limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Open on SEC EDGAR
Frost Gamma Investments Trust10% owner
Phillip MD et AL FrostDirector · CEO & Chairman · 10% owner
4
Filed Nov 18, 2025Period of report Nov 18, 20250001193125-25-286448
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 18, 2025
Common StockF1410$1.245$510.45214,386,858IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF149,590$1.25$61.99K214,436,448IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF166,635$1.255$83.63K214,503,083IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF115,000$1.265$18.98K214,564,783IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF11,772$1.27$2.25K214,566,555IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF1212,608$1.275$271.08K214,779,163IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF169,728$1.28$89.25K214,848,891IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF1428$1.2847$549.85214,849,319IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF183,556$1.285$107.37K214,932,875IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF11$1.2859$1.29214,932,876IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF133,572$1.29$43.31K214,966,448IndirectSee Footnote
Filing footnotes · 2
  1. F1The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  2. F2These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of seven limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.